| Characteristics and quality of randomized controlled trials in the treatment of hepatocellular carcinoma. | |
| | |
MedLine Citation:
|
PMID: 17342387 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Although many randomized controlled trials (RCTs) have been performed to date in the field of the treatment for hepatocellular carcinoma (HCC), there has not been any detailed analysis or evaluation of the quality of these RCTs. This study analyzed the characteristics and quality of RCTs investigating the treatment of HCC. A MEDLINE search was performed to identify prospective RCTs investigating HCC treatment published between 1991 and 2005. Eligible RCTs were analyzed by using several items, such as publication year, geographic area, and study theme. Moreover, all RCTs were evaluated by grading five items, including sample size, calculation of sample size, intention-to-treat analysis, mean observational period, loss to follow-up rate, and summing of each point. Seventy-five articles were eligible for review. Geographically, more than half of RCTs (46 RCTs) were performed in Asia, 25 RCTs in Europe, and 3 RCTs in North America. RCTs concerning transarterial chemoembolization were most frequently performed, and RCTs on hormonal therapy, ablation therapy, and chemotherapy follow thereafter in numerical order. The mean total scores were not high, although scores have recently increased. The six high-grade RCTs were all published in the recent 5 years. Many RCTs on the treatment of HCC have been performed all over the world, especially in Asia and Europe. The quality of these RCTs is, however, unsatisfactory and most of the RCTs are still inadequately performed. High-quality RCTs are needed to establish common therapeutic guidelines. |
| | |
Authors:
|
Toshimi Kaido |
Related Documents
:
|
20194997 - Helping states enhance health care quality through technical assistance. 9385727 - Commentary: quality and managed care: where is the fit? 16248717 - Giving up and giving in: the costs and benefits of daily sacrifice in intimate relation... 10129027 - Continuous quality improvement in home care: do it right the first time. 20478097 - Recording care time in nursing homes: development and validation of the "rud-foca" (res... 21508807 - Organ donation after circulatory death: vital partnerships. |
Publication Detail:
|
Type: Journal Article; Review Date: 2007-03-07 |
Journal Detail:
|
Title: Digestive diseases and sciences Volume: 52 ISSN: 0163-2116 ISO Abbreviation: Dig. Dis. Sci. Publication Date: 2007 Apr |
Date Detail:
|
Created Date: 2007-03-23 Completed Date: 2007-05-24 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 7902782 Medline TA: Dig Dis Sci Country: United States |
Other Details:
|
Languages: eng Pagination: 1108-13 Citation Subset: AIM; IM |
Affiliation:
|
Department of Surgery, Otsu Municipal Hospital, 2-9-9 Motomiya, Otsu, Shiga 520-0804, Japan. kaido3@hotmail.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Carcinoma, Hepatocellular
/
therapy* Humans Liver Neoplasms / therapy* Randomized Controlled Trials as Topic / standards* |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Down-regulation of PGE2 by physiologic levels of celecoxib is not sufficient to induce apoptosis or ...
Next Document: Giant heterotopic pancreas presenting with massive upper gastrointestinal bleeding.